|
Flemming Ørnskov
Chairman of the Board, President, Pharmaceuticals and OTC, Bausch & Lomb, Inc |
|
|
Claus Bræstrup
MSc in Chemical Engineering and Biochemistry |
|
|
Martien van Osch
Managing Partner, Forbion Capital Partners |
|
|
Edwin de Graaf
Managing Director and General Partner, Gilde Healthcare Partners |
|
|
Søren Carlsen
Managing Partner, Novo Seeds and Novo Ventures, Novo A/S |
|
|
Walter Wenninger
PhD, MBA (Dipl.Kfm.) |
|
|
Hans Küpper
Partner, Global Life Science Ventures |
|
|
Claus Andersson
Investment Director, Sunstone Capital - Life Sciences |
|
